Literature DB >> 16059873

Applications of accelerator mass spectrometry for pharmacological and toxicological research.

Karen Brown1, Elaine M Tompkins, Ian N H White.   

Abstract

The technique of accelerator mass spectrometry (AMS), known for radiocarbon dating of archeological specimens, has revolutionized high-sensitivity isotope detection in pharmacology and toxicology by allowing the direct determination of the amount of isotope in a sample rather than measuring its decay. It can quantify many isotopes, including 26Al, 14C, 41Ca, and 3H with detection down to attomole (10(-18)) amounts. Pharmacokinetic data in humans have been achieved with ultra-low levels of radiolabel. One of the most exciting biomedical applications of AMS with 14C-labeled potential carcinogens is the detection of modified proteins or DNA in tissues. The relationship between low-level exposure and covalent binding of genotoxic chemicals has been compared in rodents and humans. Such compounds include heterocyclic amines, benzene, and tamoxifen. Other applications range from measuring the absorption of 26Al to monitoring 41Ca turnover in bone. In epoxy-embedded tissue sections, high-resolution imaging of 14C label in cells is possible. The uses of AMS are becoming more widespread with the availability of instrumentation dedicated to the analysis of biomedical samples. Copyright 2005 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16059873     DOI: 10.1002/mas.20059

Source DB:  PubMed          Journal:  Mass Spectrom Rev        ISSN: 0277-7037            Impact factor:   10.946


  10 in total

Review 1.  Accelerator mass spectrometry-enabled studies: current status and future prospects.

Authors:  Ali Arjomand
Journal:  Bioanalysis       Date:  2010-03       Impact factor: 2.681

2.  Toxicokinetics of benzo[a]pyrene in humans: Extensive metabolism as determined by UPLC-accelerator mass spectrometry following oral micro-dosing.

Authors:  Erin Madeen; Lisbeth K Siddens; Sandra Uesugi; Tammie McQuistan; Richard A Corley; Jordan Smith; Katrina M Waters; Susan C Tilton; Kim A Anderson; Ted Ognibene; Kenneth Turteltaub; David E Williams
Journal:  Toxicol Appl Pharmacol       Date:  2018-12-21       Impact factor: 4.219

3.  Carbon isotopes profiles of human whole blood, plasma, red blood cells, urine and feces for biological/biomedical 14C-accelerator mass spectrometry applications.

Authors:  Seung-Hyun Kim; Jennifer C Chuang; Peter B Kelly; Andrew J Clifford
Journal:  Anal Chem       Date:  2011-03-31       Impact factor: 6.986

4.  Yeast dynamic metabolic flux measurement in nutrient-rich media by HPLC and accelerator mass spectrometry.

Authors:  Benjamin J Stewart; Ali Navid; Kenneth W Turteltaub; Graham Bench
Journal:  Anal Chem       Date:  2010-11-09       Impact factor: 6.986

Review 5.  Use of Accelerator Mass Spectrometry in Human Health and Molecular Toxicology.

Authors:  Heather A Enright; Michael A Malfatti; Maike Zimmermann; Ted Ognibene; Paul Henderson; Kenneth W Turteltaub
Journal:  Chem Res Toxicol       Date:  2016-10-11       Impact factor: 3.739

6.  Distribution and metabolism of [14C]-resveratrol in human prostate tissue after oral administration of a "dietary-achievable" or "pharmacological" dose: what are the implications for anticancer activity?

Authors:  Hong Cai; Edwina N Scott; Robert G Britton; Emma Parrott; Ted J Ognibene; Michael Malfatti; Masood Khan; William P Steward; Karen Brown
Journal:  Am J Clin Nutr       Date:  2021-05-08       Impact factor: 7.045

7.  Human in Vivo Pharmacokinetics of [(14)C]Dibenzo[def,p]chrysene by Accelerator Mass Spectrometry Following Oral Microdosing.

Authors:  Erin Madeen; Richard A Corley; Susan Crowell; Kenneth Turteltaub; Ted Ognibene; Mike Malfatti; Tammie J McQuistan; Mary Garrard; Dan Sudakin; David E Williams
Journal:  Chem Res Toxicol       Date:  2014-12-10       Impact factor: 3.739

8.  A Phase 1 Study to Assess Mass Balance and Absolute Bioavailability of Zimlovisertib in Healthy Male Participants Using a 14 C-Microtracer Approach.

Authors:  Ravi Shankar P Singh; Martin E Dowty; Mikhail Salganik; Joanne I Brodfuehrer; Gregory S Walker; Raman Sharma; Jean S Beebe; Spencer I Danto
Journal:  Clin Pharmacol Drug Dev       Date:  2022-05-04

9.  Cancer chemoprevention: Evidence of a nonlinear dose response for the protective effects of resveratrol in humans and mice.

Authors:  Hong Cai; Edwina Scott; Abeer Kholghi; Catherine Andreadi; Alessandro Rufini; Ankur Karmokar; Robert G Britton; Emma Horner-Glister; Peter Greaves; Dhafer Jawad; Mark James; Lynne Howells; Ted Ognibene; Michael Malfatti; Christopher Goldring; Neil Kitteringham; Joanne Walsh; Maria Viskaduraki; Kevin West; Andrew Miller; David Hemingway; William P Steward; Andreas J Gescher; Karen Brown
Journal:  Sci Transl Med       Date:  2015-07-29       Impact factor: 17.956

Review 10.  Recent advances in biomedical applications of accelerator mass spectrometry.

Authors:  Sang Soo Hah; Paul T Henderson; Kenneth W Turteltaub
Journal:  J Biomed Sci       Date:  2009-06-17       Impact factor: 8.410

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.